Latest updates for Amyloid-Ss

Fresh curated links around Amyloid-ß are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Amyloid-β Seeding as a Basis for a Blood Test for Alzheimer's Disease
  • High reelin expression may explain why a subgroup of entorhinal cortex neurons functions as an initial nucleation site o
  • Clinicopathologic Study Reveals Amyloid Clearance in Alzheimer’s Disease

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fightaging.org /1 week ago

Amyloid-β Seeding as a Basis for a Blood Test for Alzheimer's Disease

Blood tests to assess Alzheimer's disease risk and progression exist, for example based on the presence of circulating varieties of tau protein, but there is a great deal of room f...

Read source
journals.plos.org /2 weeks ago

High reelin expression may explain why a subgroup of entorhinal cortex neurons functions as an initial nucleation site o...

by Asgeir Kobro-Flatmoen, Jagir R. Hussan, Peter J. Hunter, Stig W. Omholt The entorhinal cortex (EC) plays a crucial role in memory functions. Long before the clinical symptoms o...

Read source
bioengineer.org /1 month ago

Clinicopathologic Study Reveals Amyloid Clearance in Alzheimer’s Disease

A recent case report published in JAMA has shed new light on the mechanisms involved in amyloid clearance following amyloid-targeting therapies for Alzheimer’s disease. This ground...

Read source
pharmexec.com /2 weeks ago

<![CDATA[Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline]]>

Read source
sciencedaily.com /2 weeks ago

A major Alzheimer’s risk gene may shrink brain cells years before symptoms

Researchers have uncovered a possible reason why the Alzheimer’s risk gene APOE4 can disrupt the brain long before memory problems begin. In mice, APOE4 increased a protein called...

Read source
fightaging.org /5 days ago

Suggesting ERBB4 Overexpression as an Important Mechanism in Alzheimer's Disease

Researchers here suggest that increased ERBB4 expression in neurons is an important driving mechanism in the onset and progression of Alzheimer's disease. One has to be cautious wi...

Read source
theheartysoul.com /3 weeks ago

A Rare Alzheimer’s Mutation Just Revealed a Protein Fold Nobody Had Ever Seen

A never-before-seen amyloid fold linked to the Flemish APP mutation may explain why amyloid-beta targets blood vessels in a rare The post A Rare Alzheimer’s Mutation Just Revealed...

Read source
sciencedaily.com /3 weeks ago

A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it

An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. The trea...

Read source
fightaging.org /1 month ago

SORLA Upregulation as a Possible Means to Treat Tauopathies

A number of neurodegenerative conditions, including Alzheimer's disease, are characterized by a pervasive chemical alteration of tau protein that causes tau to cease its normal fun...

Read source
scitechdaily.com /1 month ago

Rare Human Brain Study Reveals How an Alzheimer’s Drug May Protect the Brain

Clearing amyloid plaques may break the chain reaction that fuels brain cell destruction in Alzheimer’s disease. One Alzheimer’s brain offered researchers something they almost neve...

Read source
bioengineer.org /3 weeks ago

Cortical thinning precedes high amyloid levels by at least seven years

A new study in Nature Neuroscience reports that changes in the thickness of the cerebral cortex can appear at least seven years before amyloid reaches high levels in the brain, cha...

Read source
pharmexec.com /1 week ago

<![CDATA[Beyond Amyloid, Part Two (of two): Delivery, Diagnostics and the Path to Combination Care]]>

Read source
sciencealert.com /4 weeks ago

Never-Before-Seen Type of Amyloid May Explain a Devastating Form of Alzheimer's

Alzheimer's just gave up another one of its secrets.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Read source
japantimes.co.jp /1 month ago

Japan scientists identify clusters of protein believed to trigger Alzheimer’s disease

The discovery of a new seed of the amyloid beta protein could lead to early-stage therapy for neurodegenerative disease, according to researchers.

Read source
seekingalpha.com /1 month ago

Amyloidosis Continues To Fight Back

Read source
fightaging.org /1 month ago

Quantifying the Risk of Alzheimer's Disease Associated with High Levels of p-tau217 in Blood

The first predictive blood tests for future risk of Alzheimer's disease were developed in recent years based on correlations between marker proteins in the blood and disease risk d...

Read source
newatlas.com /5 days ago

Origins of Alzheimer's protein challenges assumptions on disease

A protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists thought, according to a recent study out of Columbia Universi...

Read source
fightaging.org /5 days ago

Targeted Reduction of PTBP1 Reverses Cognitive Impairment in a Mouse Model of Alzheimer's Disease

Many of the more sophisticated forms of medicine, including gene therapies and immunotherapies, are challenging to deliver to the brain. At the very least there are far fewer pract...

Read source
inc.com /4 weeks ago

An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid

Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.

Read source
sciencedaily.com /1 month ago

Scientists discover a protein that protects the brain from Alzheimer’s damage

A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atro...

Read source
sciencealert.com /1 month ago

It's Not Amyloid Plaques Stealing Sleep in Alzheimer's – It's Immune Cells

Breaking the feedback loop.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Read source
sciencedaily.com /1 month ago

APOE2 may protect the brain from Alzheimer’s and aging

The longevity-linked APOE2 gene appears to protect brain cells by reducing DNA damage and helping neurons recover from stress. The finding could open a new path toward treatments t...

Read source
fiercebiotech.com /1 month ago

AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline

Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharma’s decision to race the molecule into p...

Read source
fightaging.org /2 days ago

Engineered Exosomes as a Treatment for Alzheimer's Disease

Exosomes are one category of extracellular vesicle secreted by cells, a membrane-wrapped package of molecules, one complex component of the extensive, incompletely mapped communica...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Amyloid-Ss

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source

newatlas.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source